官方服务：
资源简介：
Carbon-ion radiotherapy of human lung cancer
应用场景：
创建时间：
2014-04-20
相关数据集
Lung Cancer Therapeutics Market Share and Segmentation Analysis (2024-2033)
Analyze the market segmentation of the Lung Cancer Therapeutics industry. Gain insights into market share distribution with a detailed breakdown of key segments and their growth.
www.emergenresearch.com2023-12-21 更新90
Association between time to progression and subsequent survival in ceritinib-treated patients with advanced ALK-positive non-small cell lung cancer
Objective : Time to progression (TTP) is a surrogate marker of overall survival (OS). However, OS is also dependent on post-progression survival (PPS). This study evaluated the association betwe
DataCite Commons2020-09-04 更新70
Pseudohypoxia induced by iron chelator activates tumor immune response in lung cancer
Hypoxia-inducible factor (HIF) signaling plays a critical role in immune cell function. Pseudohypoxia is characterized as iron-mediated stabilization of HIF-1α under normoxic conditions, which can be
DataCite Commons2025-10-14 更新50
Lung Cancer Therapeutics Market Size, Share & Growth Analysis Report to 2030
Lung Cancer Therapeutics
www.researchcorridor.com70
Supplementary Material for: Osimertinib in the Treatment of EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
Background: Non-small cell lung cancer (NSCLC) accounts for about 85% of generally reported lung cancer patients. Objectives: This is a systematic review of the clinical ef
DataCite Commons2023-01-10 更新60
